Candida albicans or Candida dubliniensis?

Mycoses

Volumn 54, Issue 1, 2011, Pages 1-16

  Ells, Ruan ^a   Kock, Johan L F ^a   Pohl, Carolina H ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Candida albicans; Candida dubliniensis; Genotypic identification; Phenotypic identification

Indexed keywords

AGAR; CARBOHYDRATE; CHROMOGENIC SUBSTRATE; METHYL BLUE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGAR MEDIUM; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CHLAMYDOSPORE; ELECTROPHORETIC KARYOTYPING; FLUORESCENCE ANALYSIS; FUNGUS GROWTH; GENE SEQUENCE; GENOTYPE; KARYOTYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE ANALYSIS; SEROLOGY; STRAIN DIFFERENCE; TEMPERATURE;

ANIMALS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; MYCOLOGICAL TYPING TECHNIQUES;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 78649843293     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01759.x     Document Type: Review

References (101)

1. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardised method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-9.
2. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-376.
3. Niewerth M, Korting HC. Candida albicans and the principle of opportunism. An essay. Mycoses 2002; 45: 253-8.
4. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV infected individuals. Microbiology 1995; 141: 1507-21.
5. Al-Mosaid A, Sullivan DJ, Salkin IF, Shanley D, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and Caffeic acid-ferric citrate agar. J Clin Microbiol 2001; 39: 323-7.
6. Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002; 42: 207-27.
7. Jewtuchowicz VM, Mujica MT, Brusca MI et al. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina. Oral Microbiol Immunol 2008; 23: 505-9.
8. Sullivan DJ, Coleman DC. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329-34.
9. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Biofilm formation by C. dubliniensis. J Clin Microbiol 2001; 39: 3234-40.
10. Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AMAA, Kelley JI, Meiller TF. Retrospective identification and characterisation of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV) infected and non-HIV infected individuals. J Clin Microbiol 2000; 38: 2423-26.
11. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998; 6: 2869-73.
12. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557-67.
13. Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W, Richardson AC. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 2002; 68: 3622-27.
14. Perry JD, Freydiere AM. The application of chromogenic media in clinical microbiology. J Appl Microbiol 2002; 103: 2046-55.
15. Sullivan DJ, Moran GP, Donnelly S et al. Candida dubliniensis: An update. Rev Iberoam Micol 1999; 16: 72-76.
16. TM Candida. Diagn Microbiol Infect Dis 2000; 38: 147-50.
17. Álvarez MI, Suárez BL, Caicedo LD. Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotypic methods. Mycopathologia 2009; 167: 19-24.
18. Kurzai O, Korting H-C, Harmsen D et al. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med 2000; 78: 521-9.
19. Mähnß B, Stehr F, Scäfer W, Neuber K. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 2005; 48: 55-61.
20. Pincus DH, Coleman DC, Pruitt WR et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; 37: 3533-39.
21. Ilkit M, Hilmioglu S, Tasbakan M, Aydemir S. Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identification of vaginal yeast isolates. J Med Microbiol 2007; 56: 762-5.
22. Velegraki A, Logotheti M. Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2, 3, 5, -triphenyltetrazolium chloride. FEMS Immunol Med Microbiol 1998; 20: 239-41.
23. Giammanco GM, Pizzo G, Pecorella S, Distefano S, Pecoraro V, Milici ME. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects. Oral Microbiol Immunol 2002; 17: 89-94.
24. Ellepola ANB, Hurst SF, Elie CM, Morrison CJ. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods. Oral Microbiol Immunol 2003; 18: 379-88.
25. Kirkpatrick WR, Revankar SG, McAtee RK et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007-12.
26. Al-Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 2003; 41: 4787-9.
27. Sahand IH, Moragues MD, Eraso E, Villar-Vidal M, Quindós G, Pontón J. Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis. J Clin Microbiol 2005; 43: 5768-70.
28. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2004; 42: 4796-98.
29. Kumar CPG, Menon T. Tobacco agar: a new medium for chlamydosporulation in Candida albicans and Candida dubliniensis. Med Mycol 2005; 43: 473-5.
30. Staib P, Morschhäuser J. Chlamydospore formation on Staib agar as a species specific characteristic of Candida dubliniensis. Mycoses 1999; 42: 521-4.
31. Wabale VR, Kagal AS, Mani RS, Bharadwaj RA. A novel method for differentiation of Candida dubliniensis from other Candida species. Indian J Med Microbiol 2007; 25: 304-5.
32. Alves SH, De Loreto ES, Linares CE et al. Comparison among tomato juice agar with other three media for differentiation of Candida dubliniensis from Candida albicans. Rev Inst Med Trop Sao Paulo 2006; 48: 119-21.
33. De Loreto ES, Bolzan AR, Linares CEB, Boff E, Santurio JM, Alves SH. Evaluation of 5 new media containing extracts of seeds applied to Candida dubliniensis screening. Diagn Microbiol Infect Dis 2006; 55: 191-3.
34. De Loreto S, Pozzatti P, Scheid LA, Santurio D, Santurio JM, Alves SH. Differentiation of Candida dubliniensis from Candida albicans on rosemary extract agar and oregano extract agar. J Clin Lab Anal 2008; 22: 172-7.
35. Schoofs A, Odds EC, Colebunders R, Ieven M, Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV infected patients. Eur J Clin Microbiol Infect Dis 1997; 16: 296-300.
36. Yücesoy M, Esen N, Yuluǧ N. Use of chromogenic tube and methyl blue-sabouraud agar for the identification of Candida albicans strains. Kobe J Med Sci 2001; 47: 161-167.
37. Alves SH, Milan EP, De Laet Sant'Ana P, Oliveira LO, Santurio JM, Colombo AL. Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis. Diagn Microbiol Infect Dis 2002; 43: 85-86.
38. Ahmad S, Khan Z, Mokaddas E, Khan ZA. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 2004; 53: 633-7.
39. Ahmad S, Mokaddas E, Al-Sweih N, Khan ZU. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait. Med Princ Pract 2005; 14(Suppl 1): 77-83.
40. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998; 36: 2093-5.
41. Gales AC, Pfaller MA, Houston AK et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and a-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol 1999; 37: 3804-8.
42. Loïez C, Wallet F, Sendid B, Courcol RJ. Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. Diagn Microbiol Infect Dis 2006; 56: 455-7.
43. Cárdenes-Perera C-D, Torres-Lana A, Alonso-Vargas R et al. Evaluation of API ID 32C and Vitek-2 to identify Candida dubliniensis. Diagn Microbiol Infect Dis 2004; 50: 219-21.
44. Alves SH, Horta JA, Milan EP et al. Carbohydrate assimilation profiles of Brazilian Candida dubliniensis isolates based on ID 32C system. Rev Inst Med Trop Sao Paulo 2005; 47: 109-111.
45. Szabó Z, Tóth B, Kovács M et al. Evaluation of the new Micronaut-Candida system compared to the API ID 32C method for yeast identification. J Clin Microbiol 2008; 46: 1824-25.
46. Tintelnot K, Haase G, Seibold M et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599-1608.
47. Campanha NH, Neppelenbroek KH, Spolidorio DMP, Spolidorio LC, Pavarina AC. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Disease 2005; 11: 392-8.
48. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 2005; 48: 347-51.
49. Coleman D, Sullivan D, Harrington B et al. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Disease 1997; 3(Suppl 1): S96-S101.
50. Bikandi J, Millan RS, Moragues MD et al. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and C. albicans germ tubes. J Clin Microbiol 1998; 36: 2428-33.
51. Moragues MD, Omaetxebarria MJ, Elguezabal N et al. Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections. J Clin Microbiol 2001; 39: 2999-3001.
52. Bliss JM, Sullivan MA, Malone J, Haidaris CG. Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae. J Clin Microbiol 2003; 41: 1152-60.
53. Haidaris CG, Malone J, Sherrill LA et al. Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens. J Immunol Methods 2001; 257: 185-202.
54. Marot-Leblond A, Grimaud L, David S et al. Evaluation of a rapid immunochromographic assay for identification of Candida albicans and Candida dubliniensis. J Clin Microbiol 2004; 42: 4956-60.
55. Marot-Leblond A, Beucher B, David S, Nail-Billaud S, Robert R. Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 2006; 44: 138-42.
56. ® to distinguish Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 2006; 55: 165-67.
57. Chryssanthou E, Fernandez V, Petrini B. Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics. AMPIS 2007; 115: 1281-4.
58. Marcos-Arias C, Vicente JL, Sahand IH. Isolation of Candida albicans in denture stomatitis. Arch Oral Biol 2009; 54: 127-131.
59. Neppelenbroek KH, Campanha NH, Spolidorio DMP, Spolidorio LC, Seó RS, Pavarina AC. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Oral Disease 2006; 12: 242-53.
60. Cunningham MJ, Noble WC. SDS-PAGE protein patterns of yeasts from human sources. Mycoses 1989; 32: 344-8.
61. Rosa EAR, Rosa RT, Pereira CV, Boriollo MFG, Höfling JF. Analysis of parity between protein-based electrophoretic methods for the characterization of oral Candida species. Mem Inst Oswaldo Cruz 2000; 95: 801-6.
62. Rosa EAR, Rosa RT, Boriollo MFG, Bernardo WLC, Höfling JF. Oral Candida albicans and Candida dubliniensis differentiation by multilocus enzyme electrophoresis and sodium dodecylsulphate-polyacrylamide gel electrophoresis. Rev Argent Microbiol 2003; 35: 24-28.
63. Boerlin P. Applications of multilocus enzyme electrophoresis in medical microbiology. J Microbiol Methods 1997; 28: 221-31.
64. Gil-Lamaignere C, Roilides E, Hacker J, Müller F-MC. Molecular typing for fungi - a critical review of the possibilities and limitations of currently and future methods. Clin Microbiol Infect 2003; 9: 172-185.
65. Boerlin P, Boerlin-Petzold F, Durussel C et al. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus positive drug users. J Clin Microbiol 1995; 33: 1129-35.
66. Timmins EM, Howell SA, Alsberg BK, Noble WC, Goodacre R. Rapid differentiation of closely related Candida species and strains by pyrolysis-mass spectrometry and Fourier transform-infrared spectroscopy. J Clin Microbiol 1998; 36: 367-74.
67. Maquelin K, Kirschner C, Choo-Smith L-P et al. Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood cultures. J Clin Microbiol 2003; 41: 324-9.
68. Tietz H-J, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses 2001; 44: 437-45.
69. Diaz-Guerra TM, Mellado E, Estrella MC, Laguna F, Rodriguez-Tudela JL. Molecular characterization by PCR-fingerprinting of Candida dubliniensis strains isolated from two HIV-positive patients in Spain. Diagn Microbiol Infect Dis 1999; 35: 113-9.
70. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Mühlschlegel FA. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 1999; 37: 1587-90.
71. Joly S, Pujol C, Rysz M, Vargas K, Soll DR. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J Clin Microbiol 1999; 37: 1035-44.
72. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Replacement of Candida albicans with C. dubliniensis in Human Immunodeficiency Virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 2002; 40: 3135-9.
73. Blignaut E, Pujol C, Joly S, Soll DR. Racial distribution of Candida dubliniensis colonisation among South Africans. J Clin Microbiol 2003; 41: 1838-42.
74. Fujita S-I, Hashimoto T. DNA fingerprinting patterns of Candida species using HinfI endonuclease. Int J Syst Evol Microbiol 2000; 50: 1381-9.
75. Irobi J, Schoofs A, Goossens H. Genetic identification of Candida species in HIV-positive patients using the polymerase chain reaction and restriction fragment polymorphism analysis of its DNA. Mol Cell Probes 1999; 14: 401-6.
76. McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 1999; 37: 417-21.
77. Park S, Wong M, Marras SAE et al. Rapid identification of Candida dubliniensis using a species-specific molecular probe. J Clin Microbiol 2000; 38: 2829-36.
78. Graf B, Trost A, Eucker J, Göbel UB, Adam T. Rapid and simple differentiation of C. dubliniensis from C. albicans. Diagn Microbiol Infect Dis 2004; 48: 149-51.
79. Ruhnke M, Grosch-Worner I, Lischewski A et al. Genotypic relatedness of yeast isolates from women infected with human immunodeficiency virus and their children. Mycoses 1999; 42: 385-94.
80. Mariano P, Milan EP, Da Matta DA, Colombo AL. Candida dubliniensis identification in Brazilian yeast stock collection. Mem Inst Oswaldo Cruz 2003; 98: 533-8.
81. Bautista-Muñoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodriguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 2003; 41: 414-20.
82. Rocha BA, Barbaro del Negro GM, Yamamoto L, De Souza MVB, Precioso AR, Okay TS. Identification and differentiation of Candida species from paediatric patients by random amplified polymorphic DNA. Rev Soc Bras Med Trop 2008; 41: 1-5.
83. Barros LM, Boriollo MFG, Alves ACBA, Klein MI, Gonçalves RB, Höfling JF. Genetic diversity and exoenzyme activities of Candida albicans and Candida dubliniensis isolated from the oral cavity of Brazilian periodontal patients. Arch Oral Biol 2008; 53: 1172-78.
84. Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13: 332-70.
85. Borst A, Theelen B, Reinders E, Boekhout T, Fluit AC, Savelkou PHM. Use of amplified fragment length polymorphism to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol 2003; 41: 1357-62.
86. Ball LM, Bes MA, Theelen B, Boekhout T, Egeler RM, Kuijper EJ. Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogenic stem cell transplantation. J Clin Microbiol 2004; 42: 1673-79.
87. Jabra-Rizk MA, BAqui AAMA, Kelley JI, Falkler WA Jr, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study in the United States. J Clin Microbiol 1999; 37: 321-6.
88. Magee BB, Sanchez MD, Saunders D, Harris D, Berriman M, Magee PT. Extensive chromosome rearrangements distinguish the karyotype of the hypovirulent species Candida dubliniensis from the virulent Candida albicans. Fungal Genet Biol 2008; 45: 338-50.
89. Zwart G, Van Hannen EJ, Kamst-van Agterveld MP et al. Rapid screening for freshwater bacterial groups by using reverse line hybridization. Appl Environ Microbiol 2003; 69: 5875-83.
90. Xiang H, Xiong L, Liu X, Tu Z. Rapid simultaneous detection and identification of six species Candida using polymerase chain reaction and reverse line hybridization assay. J Microbiol Methods 2007; 69: 282-87.
91. Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 2007; 45: 906-14.
92. Somogyvari F, Doczi I, Serly J, Ahmad S, Nagy E. Rapid discrimination between Candida albicans and Candida dubliniensis by using real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2007; 58: 367-9.
93. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C. Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 2008; 46: 3021-7.
94. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NAR. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144: 829-38.
95. Ramos JP, Rosa CA, Carvalho EMM, Leoncini O, Valente P. Heteroduplex mobility assay of the 26S rDNA D1/D2 region for differentiation of clinically relevant Candida species. Antonie Van Leeuwenhoek 2006; 89: 39-44.
96. Oliveira K, Haase G, Kurtzman C, Hydlig-Nielsen JJ, Stender H. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 2001; 39: 4138-41.
97. Donnely SM, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999; 145: 1871-82.
98. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 2002; 19: 973-89.
99. Romeo O, Criseo G. First molecular method for discriminating between Candida africana, Candida albicans and Candida dubliniensis by using hpw1 gene. Diagn Microbiol Infect Dis 2008; 62: 230-3.
100. Innings A, Ullberg M, Johansson A et al. Multiplex real-time PCR targeting the RNase P RNA gene for detection and identification of Candida species in blood. J Clin Microbiol 2007; 45: 874-880.
101. Manarelli BM, Kurtzman CP. Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCR. J Clin Microbiol 1998; 36: 1634-41.